Hydroponic Fortification and Dietary App Effect on Nutrients Level (Harvest)
Launched by QUADRAM INSTITUTE BIOSCIENCE · Feb 13, 2023
Trial Information
Current as of July 06, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Iron is present in plant and animal-derived foods but the fractional absorption of iron from plant foods (that is the percent of iron absorbed from a consumed quantity) is often low (approx 10%) compared to iron from animal sources 25%-30%. It is therefore more challenging for vegans and vegetarians to achieve the Reference Nutrient Intake (RNI) for iron (8.7 mg/day for men over 18 and women over 50, 14.8 mg/day for women aged 18-50), and they are likely to absorb less of that iron and therefore are more likely to become iron depleted.
Plants do not synthesise vitamin B12 and unless fortif...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Women over 18 years with a regular menstruation cycle (\>21 and \<40 days).
- • 2. Has followed a vegan or vegetarian diet that does not include the consumption of meat or fish for at least 1 year.
- • 3. Willing to remain on their background diet for the duration of the study.
- • 4. Those who are on a routine regimen of iron and/or vitamin B12 supplements must maintain the same doses 3 month prior to the study and during the duration of the study.
- • 5. Non-anaemic, haemoglobin (Hb) concentration ≥120 g/L.
- • 6. SF \>15 µg/L and \<60 µg/L \[WHO uses the following cut-offs for context: below 15 µg/L indicates iron deficiency, 16-40 µg/L indicates borderline deficiency, and 41 - 150 µg/L is normal\].
- • 7. Body Mass Index (BMI) between 18.5 - 40 kg/m2.
- • 8. Live within 40 miles of the Norwich Research Park.
- • 9. Willing to consume plants grown in the hydroponic unit (e.g., spinach, rocket, mizuna) if they agreed to have a unit.
- • 10. Access to a smartphone or online platform a well as access to the internet.
- Exclusion Criteria:
- • 1. Those who have known allergies to the hydroponically grown salad greens (spinach, rocket, mizuna).
- • 2. Flexitarian (consumes meat intermittently) vegetarian.
- • 3. Those with menstruation cycle time periods of \<21 or \>40-days
- • 4. BMI at screening visit \< 18.5 kg/m2 (underweight) and \> 40 kg/m2 (severely obese).
- • 5. Those diagnosed with or undergoing treatment for anaemia.
- • 6. Currently pregnant, lactating or trying to conceive.
- • 7. High alcohol consumption, consuming more than 2 drinks per day, can elevate the risk for iron overload.
- • 8. Current smoker or has only ceased in the last 6 months.
- • 9. Diagnosed medical conditions that may impact the study outcomes will be considered on an individual basis.
- • 10. Those with an eating disorders, which may impact the study outcome.
- • 11. On, or about to start, a diet programme such as the 5:2 programme (5:2 programme is where an individual would eat normally for five days a week, and fast for two days a week by reducing calorie consumption).
- • 12. Unable to give written or verbal informed consent.
- • 13. Individuals who cannot understand the written instructions/questionnaires.
- • 14. Unwilling to give GP contact details.
- • 15. Participating in another dietary intervention study or has given blood in another research study during the last 3 months.
- • 16. Any person related to or living with any member of the study team.
- • 17. Those who are part of the Line Manager/supervisory structure of the Chief Investigator.
- • 18. Those who have been asked to self-isolate or have been diagnosed with COVID-19 in the last 14 days. However, participants can be rescreened 7 days after the isolation period.
About Quadram Institute Bioscience
Quadram Institute Bioscience is a leading research organization dedicated to enhancing human health through innovative scientific discovery and collaboration. Focusing on the complex interactions between diet, gut microbiota, and health, the institute undertakes cutting-edge clinical trials and translational research aimed at understanding and addressing gastrointestinal diseases and their broader implications for overall well-being. With a multidisciplinary team of experts, Quadram Institute Bioscience is committed to advancing knowledge in microbiome research, nutritional science, and health innovation, ultimately translating findings into effective clinical applications and improving patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Norwich, , United Kingdom
Patients applied
Trial Officials
Paul A Kroon, PhD
Principal Investigator
Quadram Institute Bioscience
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials